The Effect of Pelvic Floor Physiotherapy on Vaginal Elasticity
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04114019 |
Recruitment Status :
Withdrawn
(The study device became unavailable for use.)
First Posted : October 3, 2019
Last Update Posted : July 27, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Stress Urinary Incontinence | Diagnostic Test: Vaginal tactile imager |
Study Type : | Observational |
Actual Enrollment : | 0 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | The Effect of Pelvic Floor Physiotherapy on Vaginal Elasticity as Measured by a Vaginal Tactile Imager |
Estimated Study Start Date : | July 1, 2020 |
Estimated Primary Completion Date : | December 30, 2020 |
Estimated Study Completion Date : | April 1, 2021 |

Group/Cohort | Intervention/treatment |
---|---|
Stress urinary incontinence
Women suffering from stress urinary incontinence
|
Diagnostic Test: Vaginal tactile imager
Vaginal elasticity evaluation using a vaginal tactile imager |
- Vaginal Elasticity [ Time Frame: From the treatment cessation up to 6 months post-treatment ]Changes in vaginal elasticity post physiotherapy
- Stress urinary incontinence [ Time Frame: From the treatment cessation up to 6 months post-treatment ]Improvement in the urogenital distress inventory questionnaire score (range 0-15)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Gender Based Eligibility: | Yes |
Gender Eligibility Description: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- women suffering from stress urinary incontinence.
Exclusion Criteria:
- women suffering from urge urinary incontinence.
- women suffering of mixed urinary incontinence.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04114019
Principal Investigator: | Roy Lauterbach, MD | Rambam Health Care Campus |
Responsible Party: | ROY LAUTERBACH MD, Principal Investigator, Rambam Health Care Campus |
ClinicalTrials.gov Identifier: | NCT04114019 |
Other Study ID Numbers: |
0327-19-RMB |
First Posted: | October 3, 2019 Key Record Dates |
Last Update Posted: | July 27, 2020 |
Last Verified: | July 2020 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Urinary Incontinence Urinary Incontinence, Stress Urination Disorders Urologic Diseases Female Urogenital Diseases |
Female Urogenital Diseases and Pregnancy Complications Urogenital Diseases Male Urogenital Diseases Lower Urinary Tract Symptoms Urological Manifestations |